GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achieve Life Sciences Inc (FRA:SP4P) » Definitions » Net Interest Income (for Banks)

Achieve Life Sciences (FRA:SP4P) Net Interest Income (for Banks)


View and export this data going back to . Start your Free Trial

What is Achieve Life Sciences Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Achieve Life Sciences (FRA:SP4P) Business Description

Traded in Other Exchanges
Address
22722 29th Dr. SE, Suite 1000, Bothell, WA, USA, 98021
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for nicotine addiction.